There were no reservations in the Former Auditor's audit reports for the period commencing at the beginning of the Company’s two most recent financial years and ending at the date of the resignation of the Former Auditor. There are no “reportable events” (as the term is defined in National Instrument 51-102 – Continuous Disclosure Obligations) between the Company and the Former Auditor.
The resignation of the Former Auditor as auditors of the Company has been approved by the Company's Board of Directors and Audit Committee. The Company's Audit Committee and Board of Directors have reviewed the Notice of Change of Auditors, together with the letter from the Former Auditor and the letter from the Successor Auditor.
About
Khiron is a vertically integrated medical and CPG cannabis company with core operations in
Leveraging its first-mover advantage, and patient oriented approach, Khiron combines global scientific expertise, product innovation, agricultural infrastructure, wholly-owned medical clinics, and online doctor education programs to drive prescription and brand loyalty to address priority medical conditions. Its Wellbeing unit launched the first branded CBD skincare brand in
Visit Khiron online at www.khiron.ca and on Instagram @khironlife
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
For further information:
Investor Contacts: E: pricardo@khiron.ca | Media Contact: Vice President, Communications T: +1 (416) 543-9179 E: jpacker@khiron.ca |
Source:
2020 GlobeNewswire, Inc., source